Jianmin Pharmaceutical Group Co Ltd Cash Flow Quality Index
Jianmin Pharmaceutical Group Co Ltd cash flow quality index. Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Quality Index of 1.44x as of December 2025. Operating cash flow of CN¥106.82 Million exceeds net income of CN¥74.10 Million, indicating high earnings quality where cash backs reported profits. See 600976 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Cash flow quality index of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. Historical Cash Flow Quality Index for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jianmin Pharmaceutical Group Co Ltd (600976) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Jianmin Pharmaceutical Group Co Ltd Cash Flow Quality Index by Year (2003–2025)
Jianmin Pharmaceutical Group Co Ltd cash flow quality index by year from 2003 to 2025. Year-by-year earnings quality comparison for Jianmin Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Jianmin Pharmaceutical Group Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | CN¥274.53 Million | CN¥359.84 Million | ▲ +17.9% |
| 2024 | 0.65x | CN¥234.27 Million | CN¥362.18 Million | ▲ +26.1% |
| 2023 | 0.51x | CN¥268.39 Million | CN¥523.23 Million | ▼ -3.6% |
| 2022 | 0.53x | CN¥215.87 Million | CN¥405.50 Million | ▼ -33.2% |
| 2021 | 0.80x | CN¥259.18 Million | CN¥325.42 Million | ▼ -5.7% |
| 2020 | 0.84x | CN¥125.54 Million | CN¥148.69 Million | ▲ +5.1% |
| 2019 | 0.80x | CN¥74.45 Million | CN¥92.63 Million | ▲ +2.7% |
| 2018 | 0.78x | CN¥63.60 Million | CN¥81.30 Million | ▲ +103.2% |
| 2017 | 0.38x | CN¥35.20 Million | CN¥91.44 Million | ▼ -78.0% |
| 2016 | 1.75x | CN¥113.84 Million | CN¥65.06 Million | ▲ +214.2% |
| 2015 | 0.56x | CN¥48.45 Million | CN¥87.00 Million | ▼ -35.8% |
| 2014 | 0.87x | CN¥103.23 Million | CN¥118.95 Million | ▲ +84.1% |
| 2013 | 0.47x | CN¥45.36 Million | CN¥96.20 Million | ▼ -60.4% |
| 2012 | 1.19x | CN¥98.17 Million | CN¥82.54 Million | ▲ +223.3% |
| 2011 | -0.97x | CN¥-75.54 Million | CN¥78.28 Million | ▼ -144.0% |
| 2010 | 2.19x | CN¥150.08 Million | CN¥68.50 Million | ▲ +52.5% |
| 2009 | 1.44x | CN¥66.69 Million | CN¥46.42 Million | ▼ -79.7% |
| 2008 | 7.08x | CN¥110.11 Million | CN¥15.55 Million | ▲ +1002.6% |
| 2007 | -0.78x | CN¥-6.88 Million | CN¥8.77 Million | ▼ -118.9% |
| 2006 | 4.15x | CN¥56.18 Million | CN¥13.55 Million | ▲ +394.8% |
| 2005 | -1.41x | CN¥-34.63 Million | CN¥24.62 Million | ▼ -1161.9% |
| 2004 | 0.13x | CN¥4.13 Million | CN¥31.20 Million | ▼ -10.3% |
| 2003 | 0.15x | CN¥4.19 Million | CN¥28.35 Million | — |